Biotech · Private company
Intima Bioscience, Inc.
Track this companyFree. Adds Intima Bioscience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- AldesleukinPhase 2 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- AldesleukinPhase 2 · Gastrointestinal Epithelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- CISH Inactivated TILPhase 2 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Gastrointestinal Epithelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Gastrointestinal Epithelial CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- Tumor-Infiltrating Lymphocytes (TIL)Phase 2 · Gastrointestinal Epithelial CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- CISH Inactivated TILs in the Treatment of NSCLCPHASE1_PHASE2 · WITHDRAWN · started Feb 1, 2023ClinicalTrials.gov NCT05566223 · fetched Nov 12, 2026
- A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringPHASE1_PHASE2 · COMPLETED · started May 15, 2020ClinicalTrials.gov NCT04426669 · fetched Nov 12, 2026